Clinical Trials

NCT06305754 | ACTIVE_NOT_RECRUITING | PHASE3
520 participants

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2024-06-11
Completion:
2028-08-17
Conditions
  • Non-small Cell Lung Cancer (NSCLC)
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT06124157 | RECRUITING | PHASE2
222 participants

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2025-05-30
Completion:
2030-12-01
Conditions
  • B Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • RADIATION
No Results Yet
NCT06112431 | WITHDRAWN | NA
0 participants

Eye Health Intervention Study in Upper Manhattan

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2027-04-01
Completion:
2031-03-31
Conditions
  • Glaucoma, Suspect
  • Diabetic Retinopathy
  • Cataract
  • Refractive Errors
  • Vision Impairment and Blindness
Interventions
  • OTHER
No Results Yet
NCT06103838 | RECRUITING | PHASE2
60 participants

18F-Fluciclovine PET/CT in Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2024-03-25
Completion:
2026-12-06
Conditions
  • Multiple Myeloma
  • Newly Diagnosed Multiple Myeloma (NDMM)
  • Relapsed and/or Refractory Multiple Myeloma (RRMM)
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page